期刊
TRENDS IN BIOTECHNOLOGY
卷 39, 期 3, 页码 225-243出版社
CELL PRESS
DOI: 10.1016/j.tibtech.2020.07.011
关键词
-
资金
- Fundacao para a Ciencia e Tecnologia, from Portugal [SFRH/BD/118871/2016]
- European Union Framework Program for Research and Innovation HORIZON 2020, under the FOOD4CELLS project [PTDC/CTM-BIO/4706/2014 -POCI-01-0145-FEDER 016716]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/118871/2016] Funding Source: FCT
This review aims to analyze the technical and scientific specificities of platelet-derived products (PDPs) in veterinary contexts to advance their future biotechnological potential. While the therapeutic effect of PDPs has been widely recognized, the lack of standard protocols to generate PDPs in veterinary medicine remains a major hurdle that needs to be addressed.
Platelet-derived products (PDPs) have gained popularity, mainly due to their high concentrations of bioactive molecules such as growth factors and cytokines, which play important roles in tissue healing and regeneration. PDPs are obtained through minimally invasive procedures and their therapeutic effect has been widely recognized. In veterinary medicine, however, the lack of standard protocols to generate PDPs is a major hurdle for assessing the clinical relevance of PDP-based therapies and for their widespread usage. The aim of this review is to analyze the technical and scientific specificities of PDPs in terms of preparation methodologies, classification categorization, nomenclature, and biological proprieties to advance their future biotechnological potential in veterinary contexts.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据